TORC1 Monoclonal Antibody

A chromosomal aberration involving CRTC1 is found in mucoepidermoid carcinomas, benign Warthin tumors and clear cell hidradenomas. Translocation t(11;19)(q21;p13) with MAML2. The fusion protein consists of the N-terminus of CRTC1 joined to the C-terminus of MAML2. The reciprocal fusion protein consisting of the N-terminus of MAML2 joined to the C-terminus of CRTC1 has been detected in a small number of mucoepidermoid carcinomas.,function:Transcriptional coactivator for CREB1 which activates transcription through both consensus and variant cAMP response element (CRE) sites. Acts as a coactivator, in the SIK/TORC signaling pathway, being active when dephosphorylated and acts independently of CREB1 'Ser-133' phosphorylation. Enhances the interaction of CREB1 with TAF4.

Introducing the TORC1 Monoclonal Antibody, a cutting-edge biotechnological innovation designed to revolutionize the field of molecular research. This meticulously crafted product is meticulously engineered to target and inhibit the activity of the TORC1 protein, a crucial regulator of cellular growth and metabolism.

The TORC1 Monoclonal Antibody boasts an exceptional level of specificity and affinity, ensuring unparalleled accuracy in its binding to the TORC1 protein. Through this highly targeted interaction, it effectively neutralizes the protein's function, thereby enabling researchers to gain invaluable insights into the intricate mechanisms underlying cellular processes.

Crafted with utmost precision, this monoclonal antibody exhibits exceptional stability and reproducibility, guaranteeing consistent and reliable results across various experimental conditions. Its exceptional purity and low endotoxin levels further enhance its suitability for a wide range of applications, including Western blotting, immunoprecipitation, and immunofluorescence.

Moreover, the TORC1 Monoclonal Antibody is meticulously validated through rigorous quality control measures, ensuring its superior performance and reliability. Each batch undergoes stringent testing to confirm its specificity, sensitivity, and consistency, thereby instilling confidence in researchers and facilitating the advancement of scientific discoveries.

With its unrivaled efficacy and versatility, the TORC1 Monoclonal Antibody is poised to revolutionize the realm of molecular research. Empower your investigations with this groundbreaking tool and unlock the mysteries of cellular growth and metabolism like never before.